Financials

News Ideas Technicals

4132 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to GOLDEN BIOTECHNOLOGY CORP operating, investing, and financing activities

4132 free cash flow for H2 23 is -113.41 M TWD. For 2023, 4132 free cash flow was -272.69 M TWD and operating cash flow was -267.81 M TWD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—